1.866.648.2767
    info@tabularasahealthcare.com

    Investors - Press Releases

    << Back
     View printer-friendly version
    Tabula Rasa HealthCare’s PACE Division Signs Agreement with CenterLight Healthcare PACE to Manage Medication Risk, Improve Quality and Outcomes

    MOORESTOWN, N.J., Aug. 29, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare Corporation (NASDAQ:TRHC), a healthcare technology company disrupting the field of medication safety, announces that the largest Program of All-Inclusive Care for the Elderly organization (PACE) has signed an agreement for medication risk management services with CareKinesis, its wholly owned subsidiary focused on PACE. CenterLight Healthcare PACE selected TRHC to work with the Interdisciplinary Care Team (IDT) to streamline workflows and improve outcomes for participants. The agreement will begin with a launch center with additional locations to be added over time in consideration of specific clinical, economic, and satisfaction-related outcomes.

    CenterLight Healthcare’s PACE Organization is a vanguard of the community physician model that enables patients to keep their primary care physician once they enroll in PACE. This model is now enabled through a waiver program. CMS is considering eliminating the waiver in its newly proposed conditions of participation to increase access to PACE. TRHC will collaborate with CenterLight network and employed prescribers and staff to reduce hospital admissions, re-admissions and total costs while increasing participant and provider satisfaction. 

    “We have been exploring options for a medication risk partner,” said CenterLight Chief Medical Officer, Dr. Thomas. “It has been a pleasure to learn about Tabula Rasa’s unique Medication Risk Mitigation® software and Medication Decision Support and Adherence tools that personalize each participant’s medication regimen. We look forward to improving quality and outcomes for our PACE participants.”

    “TRHC continues to advance the practice and science of medication risk mitigation through our personalized medicine approach,” said Chairman and CEO Calvin H. Knowlton, PhD. “We are pleased to have formalized this collaboration with CenterLight with the goal of optimizing outcomes for their participants by reducing the risk of adverse drug events while improving adherence.”

    The Agreement takes effect September 1, 2017. 

    About CenterLight Healthcare PACE
    CenterLight Healthcare is an innovative managed care organizations that excels in providing long-term healthcare services throughout the Bronx, Kings (Brooklyn), New York (Manhattan), Queens, Richmond (Staten Island), Nassau, Suffolk and Westchester counties. CenterLight’s goal is to help clients enjoy the highest possible quality of life while living safely in their own homes and communities.

    About Tabula Rasa HealthCare

    Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC, through its wholly-owned subsidiary, CareKinesis, has focused on optimizing outcomes for PACE and other healthcare organizations using its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participants medication regimen.  For more information, please visit: www.TRHC.com.

    Contact:  Media
    TRHC
    Dianne Semingson
    dsemingson@TRHC.com
    T: 215-870-0829

    Primary Logo

    Tabula Rasa HealthCare, Inc.